Suppr超能文献

妊娠的解剖学和生理学改变。

Anatomical and physiological alterations of pregnancy.

机构信息

Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Division of Clinical Pharmacology, Children's National Hospital, Washington, DC, USA.

出版信息

J Pharmacokinet Pharmacodyn. 2020 Aug;47(4):271-285. doi: 10.1007/s10928-020-09677-1. Epub 2020 Feb 6.

Abstract

The extensive metabolic demands of pregnancy require specific physiological and anatomical changes. These changes affect almost all organ systems, including the cardiovascular, respiratory, renal, gastrointestinal, and hematologic system. The placenta adds another layer of complexity. These changes make it challenging for clinicians to understand presenting signs and symptoms, or to interpret laboratory and radiological tests. Furthermore, these physiological alterations can affect the pharmacokinetics and pharmacodynamics of drugs. Drug safety in lactation is only supported by limited evidence. In addition, the teratogenic effects of medications are often extrapolated from animals, which further adds uncertainties. Unfortunately, pregnant women are only rarely included in clinical drug trials, while doses, regimens, and side effects are often extrapolated from studies conducted in non-pregnant populations. In this comprehensive review, we present the changes occurring in each system with its effects on the pharmacokinetic variables. Understanding these physiological changes throughout normal pregnancy helps clinicians to optimize the health of pregnant women and their fetuses. Furthermore, the information on pregnancy-related physiology is also critical to guide study design in this vulnerable 'orphan' population, and provides a framework to explore pregnancy-related pathophysiology such as pre-eclampsia.

摘要

妊娠的广泛代谢需求需要特定的生理和解剖变化。这些变化几乎影响所有器官系统,包括心血管、呼吸、肾脏、胃肠道和血液系统。胎盘增加了另一层复杂性。这些变化使得临床医生难以理解表现出的体征和症状,或解释实验室和影像学检查。此外,这些生理变化会影响药物的药代动力学和药效动力学。哺乳期药物安全性仅得到有限证据的支持。此外,药物的致畸作用通常是从动物身上推断出来的,这进一步增加了不确定性。不幸的是,孕妇很少被纳入临床药物试验,而剂量、方案和副作用通常是从非孕妇群体进行的研究中推断出来的。在本综述中,我们介绍了每个系统发生的变化及其对药代动力学变量的影响。了解正常妊娠过程中的这些生理变化有助于临床医生优化孕妇及其胎儿的健康。此外,与妊娠相关的生理学信息对于指导这一脆弱的“孤儿”人群的研究设计也至关重要,并为探索妊娠相关的病理生理学(如子痫前期)提供了框架。

相似文献

1
Anatomical and physiological alterations of pregnancy.妊娠的解剖学和生理学改变。
J Pharmacokinet Pharmacodyn. 2020 Aug;47(4):271-285. doi: 10.1007/s10928-020-09677-1. Epub 2020 Feb 6.
3
Pharmacokinetics of drugs in pregnancy.孕期药物的药代动力学
Semin Perinatol. 2015 Nov;39(7):512-9. doi: 10.1053/j.semperi.2015.08.003.
4
Epidemiology of medications use in pregnancy.孕期用药流行病学。
Semin Perinatol. 2015 Nov;39(7):508-11. doi: 10.1053/j.semperi.2015.08.002. Epub 2015 Sep 8.
5
Therapeutic Drug Monitoring in Pregnant Patients.治疗药物监测在孕妇中的应用。
Ther Drug Monit. 2020 Apr;42(2):172-180. doi: 10.1097/FTD.0000000000000709.
7
Medication use in pregnancy and the pregnancy and lactation labeling rule.孕期用药及妊娠和哺乳期标签规则
Clin Pharmacol Ther. 2016 Jul;100(1):23-5. doi: 10.1002/cpt.380. Epub 2016 May 9.
8
Variation of drug kinetics in pregnancy.孕期药物动力学的变化。
Curr Drug Metab. 2009 Jun;10(5):520-9. doi: 10.2174/138920009788897993.

引用本文的文献

本文引用的文献

7
Maternal kidney function during pregnancy: systematic review and meta-analysis.孕妇的肾脏功能:系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2019 Sep;54(3):297-307. doi: 10.1002/uog.20137. Epub 2019 Aug 6.
10
The role of the placenta in drug transport and fetal drug exposure.胎盘在药物转运及胎儿药物暴露中的作用。
Expert Rev Clin Pharmacol. 2018 Apr;11(4):373-385. doi: 10.1080/17512433.2018.1425615. Epub 2018 Jan 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验